Entacapone

This page contains recent news articles, when available, and an overview of Entacapone but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Entacapone
(when available)

Pharmacology and use:
Entacapone is used in the treatment of Parkinson’s disease as an adjunct to levodopa/carbidopa therapy. Entacapone is a selective and reversible inhibitor of catechol-O-methyltransferase (COMT). In mammals, COMT is distributed throughout various organs with the highest activities in the liver and kidney. COMT also occurs in the heart, lung, smooth and skeletal muscles, intestinal tract, reproductive organs, various glands, adipose tissue, skin, blood cells and neuronal tissues, especially in glial cells. COMT catalyzes the transfer of the methyl group of S-adenosyl-L-methionine to the phenolic group of substrates that contain a catechol structure. Physiological substrates of COMT include dopa, catecholamines (dopamine, norepinephrine, and epinephrine) and their hydroxylated metabolites. The function of COMT is the elimination of biologically active catechols and some other hydroxylated metabolites. In the presence of a decarboxylase inhibitor, COMT becomes the major metabolizing enzyme for levodopa, catalyzing the metabolism to 3-methoxy-4-hydroxy-L-phenylalanine (3-OMD) in the brain and periphery. For as an adjunct to levodopa / carbidopa to treat patients with idiopathic Parkinson's Disease who experience the signs and symptoms of end-of-dose "wearing-off".

Mechanism Of Action:
The mechanism of action of entacapone is believed to be through its ability to inhibit COMT and alter the plasma pharmacokinetics of levodopa. When entacapone is given in conjunction with levodopa and an aromatic amino acid decarboxylase inhibitor, such as carbidopa, plasma levels of levodopa are greater and more sustained than after administration of levodopa and an aromatic amino acid decarboxylase inhibitor alone. It is believed that at a given frequency of levodopa administration, these more sustained plasma levels of levodopa result in more constant dopaminergic stimulation in the brain, leading to greater effects on the signs and symptoms of Parkinson's disease.

News Articles on Entacapone

Orion Group Interim Report January-September 2009  -  ‎Oct 26, 2009‎
Orion expects the costs of the legal proceedings against the Sandoz companies to be substantially less than the costs of the ongoing entacapone patent ... Trading Markets (press release)

Orion withdraws US application for extending the indication of Stalevo®  -  ‎Oct 21, 2009‎
...extending the current US indication of its proprietary drug Stalevo® (levodopa, carbidopa and entacapone) to patients with early Parkinson's disease. ... PipelineReview.com (press release)

Hi vá»?ng má»›i cho bệnh nhân Parkinson  -  ‎Oct 31, 2009‎
Trong Stalevo có sá»± kết hợp giữa ba thành phần carpidopa, levodopa và entacapone. Carbidopa ức chế quá trình khá»­ carboxy cá»§a levodopa ở ngoại biên; ... Tuổi Trẻ

Drug to cut Parkinson's problems  -  Mar 12, 2005
The French team compared the effect of using rasagiline and entacapone alongside ... But while entacapone must be given several times a day, rasagiline is ... BBC News

Entacapone (Systemic).  -  Jul 28, 2005
Entacapone ( in-TACK-a-pohn)is used in combination with levodopa/carbidopa to treat Parkinson's disease, sometimes referred to as shaking palsy. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Novartis study shows Parkinson's drug controls symptoms more than …  -  Apr 15, 2008
Stalevo is a levodopa therapy combining levodopa and carbidopa with the enzyme inhibitor entacapone, which extends the presence of levodopa in the ... Forbes

Finnish Orion sues Wockhardt in US over patents  -  Sep 14, 2007
Orion said Wockhardt seeks to market in the United States generic entacapone, which is the active ingredient in Orion's Parkinson disease drug Comtan, ... Reuters

New Evidence Demonstrates Use of Stalevo Improves Quality of Life and...  -  Nov 1, 2006
Stalevo (levodopa/carbidopa/entacapone) is an enhanced levodopa therapy for the treatment of Parkinson's disease indicated for those patients experiencing ... DG News

Entacapone May Decrease Homocysteine Levels in Levodopa-Treated …  -  Mar 10, 2005
March 10, 2005 — Entacapone therapy significantly decreases elevated plasma homocysteine levels in levodopa-treated Parkinson's disease (PD) patients, ... Medscape

CARBIDOPA, ENTACAPONE, AND LEVODOPA (Oral route) - lee-voe- …  -  May 1, 2007
Carbidopa, entacapone and levodopa is used to treat Parkinson's disease, sometimes referred to as shaking palsy. Parkinson's disease is a disorder of the ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Zyvox Oral: Dosage, Uses and Warnings  -  Aug 10, 2006
CLINICAL EFFECTS: Concurrent administration of entacapone or tolcapone with a ... 4) Entacapone may be used with selegiline, provided that the daily dose of ... Medscape

Stalevo - Levodopa / Carbidopa / Entacapone - Medical Drug  -  Jul 1, 2008
Stalevo is a medicine used to relieve the symptoms of Parkinson's disease in patients who are inadequately controlled by other therapies. ... Virtual Medical Centre - The Virtual Medical Centre

A case of levodopa-responsive camptocormia associated with advanced …  -  Jan 5, 2007
The patient's medication was adjusted to CD–LD–entacapone 37.5 mg/150 mg/200 ... The switch to CD–LD–entacapone provided more reliable onset of 'on' time to ... Nature.com

Parkinson Disease; Entacapone prolongs central effects of L-DOPA in...  -  Feb 8, 2005
Long-term palliative treatment of PD "with the dopamine precursor L-3,4-dihydroxyphenylalanine (L-DOPA, levodopa) is compromised by the occurrence of motor ... Pay-Per-View - Science Letter - Factiva, from Dow Jones

entacapone Orion submitted for approval, Japan (Parkinson disease).  -  Apr 10, 2006
Novartis submitted entacapone (COMTAN) for marketing approval in Japan, ... Entacapone is a COMT inhibitor that is marketed worldwide to enhance the ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones

Parkinson Disease; Entacapone prolongs central effects of L-DOPA in...  -  Feb 11, 2005
Long-term palliative treatment of PD "with the dopamine precursor L-3,4-dihydroxyphenylalanine (L-DOPA, levodopa) is compromised by the occurrence of motor ... Pay-Per-View - Drug Week - Factiva, from Dow Jones

… of Stalevo (carbidopa, levodopa, and entacapone) has been granted...  -  Sep 3, 2007
Stalevo 200 mg (50 mg carbidopa, 200 mg levodopa, 200 mg entacapone) provides for greater dosing flexibility in the treatment of Parkinson's disease, ... $4.95 - Drug Topics - ECNext

Parkinson Disease; Entacapone prolongs central effects of L-DOPA in...  -  Feb 12, 2005
Long-term palliative treatment of PD "with the dopamine precursor L-3,4-dihydroxyphenylalanine (L-DOPA, levodopa) is compromised by the occurrence of motor ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

Parkinson's disease.(THE EFFECTIVE PHYSICIAN)(Disease/Disorder …  -  Aug 1, 2006
Entacapone and rasagiline are effective in reducing off time in PD patients receiving dopaminergic therapy. Pramipexole, ropinirole, tolcapone ... $4.95 - Internal Medicine News - ECNext

Parkinson Disease; AGILECT demonstrated improvement in levodopa- …  -  Apr 4, 2005
The positive effects seen with once-daily AGILECT were similar to those seen in patients treated with entacapone, given with each levodopa dose, ... Pay-Per-View - Clinical Oncology Week - Factiva, from Dow Jones

Stalevo.(drug overview)(Drug overview)  -  Dec 1, 2005
Carbidopa and entacapone both keep the body from breaking down levodopa too quickly, thus allowing the drug's effects to last longer. ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com

Parkinson's disease.(development of Parkinson drug treatments )  -  Jan 1, 2005
Catechol-O-methyltransferase (COMT) inhibitors, including Tolcapone (Tasmar) and entacapone, prolong the effect of levodopa by blocking an enzyme that ... Free with registration - New Medical Therapies -- Parkinson's... - AccessMyLibrary.com

FDA Approves New Dosage Strength Of Stalevo(R) For People With …  -  Aug 8, 2007
The addition of entacapone to levodopa delays the breakdown of levodopa and extends the duration of effect of each dose of levodopa. ... Medical News Today - Medical News Today (press release)

Medication may improve symptoms in Parkinson's disease.(POEMs and …  -  Nov 1, 2005
Adjuvant medications such as pergolide (Permax) or entacapone (Comtan) can provide ... Rasagiline had a similar effect to entacapone in most measures. ... Free with registration - American Family Physician - AccessMyLibrary.com

COMT inhibitors for Parkinson's disease  -  Dec 8, 2008
Doctors are also now starting to prescribe entacapone and levodopa more ... This warning and legal requirement does not apply to entacapone (Comtan) or ... WebMD

Stalevo 50 Oral : Uses, Side Effects, Interactions, Pictures,...  -  Aug 10, 2006
Comtess (entacapone) UK summary of product characteristics. Orion Pharma, UK September 16, 1998. ... Comtan (entacapone) Canadian prescribing information. ... WebMD

Q1 2007 Orion Corporation Earnings Conference Call - Final.  -  Apr 25, 2007
I suppose the sale surprises for me were in entacapone, specialty and animal health. And I'm wondering, for instance, looking at entacapone sales where, ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Novartis: Stalevo wirkt besser gegen Parkinson als Levodopa  -  Apr 15, 2008
Bei Stalevo werden die Mittel Levodopa und Carbidopa mit dem Enzymhemmer Entacapone kombiniert, um den Verbleib von Levodopa im Blutkreislauf zu verlängern. ... FinanzNachrichten.de

Managing the full course of Parkinson's disease: A hypothetical case ...  -  Sep 1, 2006
6 mo later Add a COMT inhibitor, entacapone, 200 mg qid, in the form of The patient has had ... 2 mo later (year 8) Eliminate entacapone from the regimen by ... Free with registration - Patient Care for the Nurse Practitioner - AccessMyLibrary.com

Rasagiline helps Parkinson's patients shake off symptoms  -  Apr 15, 2005
Another 227 patients received 200mg of entacapone, an inhibitor of ... Of these, 23 were receiving rasagiline, 30 entacapone and 35 placebo. ... National Review of Medicine

Helsinki shares edge up at midday in mixed trading  -  Jun 1, 2007
The broker estimates that entacapone will contribute around 40 pct of group EBIT in 2007, which it believes will lead to first-quarter returns over the next ... Forbes

Q1 2006 Orion Corporation Earnings Conference Call - Final.  -  May 8, 2006
And the Entacapone lifecycle management with the Stalevo product currently ... Firstly, I still have great problems forecasting trends for Entacapone sales. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Orion considers lawsuit to protect patent  -  Aug 13, 2007
HE) said on Monday it was evaluating its legal options to protect its patent on entacapone in the United States after a generic drugs firm sought ... Reuters

Un traitement moderne pour la maladie de Parkinson améliore le bien- …  -  Sep 18, 2008
Il contient aussi un inhibiteur d'enzyme appelé entacapone. L'entacapone permet à la lévodopa de demeurer plus longtemps dans le système sanguin puisqu'il ... LeLézard.com

Pharmacotherapy for Parkinson's disease: current options, promising …  -  Aug 1, 2006
The COMT inhibitors tolcapone and entacapone can prolong the half-life of ... Using a COMT inhibitor such as tolcapone or entacapone can increase on time ... Free with registration - JAAPA-Journal of the American Academy... - AccessMyLibrary.com

Press Release: Once-Daily AGILECT(R) Demonstrated Improvement in …  -  Mar 10, 2005
The positive effects seen with once-daily AGILECT(R) were similar to those seen in patients treated with entacapone, given with each levodopa dose, ... Pay-Per-View - PR Newswire - HighBeam Research

Higher dose of Novartis' Stalveo cleared in USA.(drug approval for …  -  Aug 13, 2007
The addition of entacapone to levodopa delays the breakdown of levodopa and extends the duration of effect of each dose. The firm noted that Stalevo ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Parkinson's disease is a complex neurological dis-order with cardinal...  -  Jul 8, 2005
There is one COMT inhibitor currently available, entacapone (Comtess) which is also ... Entacapone must be taken in conjunction with a dose of levodopa but ... Pay-Per-View - Practice Nurse - Factiva, from Dow Jones

Levodopa medications for Parkinson's disease  -  Dec 8, 2008
A catechol O-methyltransferase (COMT) inhibitor (such as entacapone), ... Stalevo, a new medicine that combines entacapone, levodopa, and carbidopa. ... WebMD

International Approvals: Tasmar, Amplimexon, IV Remodulin  -  Jan 17, 2006
The ban was lifted on the basis of data from an international 32-center, double-blind study in 150 patients optimized on levodopa and entacapone who were ... Medscape

Parkinson's medicine in patent tangle  -  Nov 4, 2008
Orion had previously sued Wockhardt for challenging the patents on Comtan (entacapone), another version of Parkinson's disease drug marketed by Novartis. ... Rediff

Rasagiline Reduces Disability For Patients With Advanced Parkinson's ...  -  Apr 9, 2005
Several drugs (pergolide, pramipexole, ropinirole, entacapone and tolcapone) when added to levodopa have been effective in the management of fluctuations ... sciencedaily.com

… sues generic drug companies in the US to enforce patents for entacap...  -  Sep 17, 2007
5135950 against generic drug companies Wockhardt USA, Inc. and Wockhardt Limited, who seek to market generic entacapone (200 mg tablets) in the United ... chemie.de

Orion Profit Falls Short of Estimates as Costs Rise  -  Aug 5, 2008
The patent on entacapone expires in 2013 in the US and in 2012 in Europe, according to an Orion presentation in November 2007. ... Bloomberg

Independent Nurse: Clinical - Neurology - Managing Parkinson's...  -  Jan 26, 2007
Tolcapone is another COMT inhibitor that can be added to levodopa, but is only used after failure of entacapone because of possible severe hepatic ... Free with registration - GP - AccessMyLibrary.com

FIRST PILL TO SLOW DOWN PARKINSON'S OFFERS NEW HOPE.  -  Jul 5, 2005
BUT WHILE entacapone must be taken several times a day, Azilect can be taken just once a day. Azilect has been a revelation for David Pickin, 69, ... Pay-Per-View - Daily Mail - Factiva, from Dow Jones

Parkinson's disease: diagnosis and treatment.(Disease/Disorder...  -  Dec 15, 2006
...(26) Carbidopa/levodopa/entacapone (Stalevo) tablets are available for patients ... Rasagiline and entacapone reduced "off" time by about 1.2 hours a day ... Pay-Per-View - American Family Physician - Factiva, from Dow Jones

Chromatography; Recent findings in chromatography described  -  Nov 15, 2005
Stability of entacapone in plasma was excellent, with no evidence of degradation during sample processing (autosampler) and 30 days storage in a freezer," ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Parkinson's disease: diagnosis and treatment.(Disease/Disorder...  -  Dec 15, 2006
...(26) Carbidopa/levodopa/entacapone (Stalevo) tablets are available for patients ... Rasagiline and entacapone reduced "off" time by about 1.2 hours a day ... $4.95 - American Family Physician - ECNext

Management of Parkinson disease: current treatments, recent advances,...  -  Sep 1, 2007
Entacapone is not associated with liver dysfunction, and no liver function ... However, entacapone is associated with both diarrhea and constipation. ... $4.95 - Formulary - ECNext

Two new treatments funded for Parkinson's disease  -  Oct 27, 2005
Ropinirole (Requip) and entacapone (Comtan) provide alternatives to treatments that are already ... Entacapone is only used as a combination treatment. ... scoop.co.nz

rasagiline Teva clinical data (phase III) (Parkinson disease).(Brief...  -  Apr 25, 2005
...rasagiline tablets once-daily, 200 mg entacapone with each levodopa dose or placebo. Results showed that patients receiving either rasagiline or entacapone ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones

Parkinson's Disease Market analysis and forecasts, 2008- 2012, 2017 &...  -  Jan 8, 2008
Comtess (Entacapone) To Aid PD Treatment. 3.7. Dopamine And COMT Combined ... Comtan (Entacapone) Leading COMT. Inhibitors Captures Tasmar's Market Share ... $4,422.00 - VISIONGAIN A - Alacra Store

New Guidelines Update Diagnosis and Treatment of Parkinson's Disease  -  Apr 4, 2006
The specific recommendation calls for the use of entacapone and rasagiline, as Dr. Pahwa described. However, the limitations of the evidence to date does ... Medscape

Clinical: Managing Parkinson's disease in the long term.  -  Mar 24, 2006
Levodopa is given with a dopa-decarboxylase inhibitor (DDCI), but entacapone, a COMT inhibitor, which reduces the degradation of levodopa in the peripheral ... Free with registration - GP - AccessMyLibrary.com

Pharmacy update - Parkinson's disease: a case study.(Case study)  -  Jan 27, 2007
The drug entacapone inhibits COMT, increasing the levels of levodopa and ... Stalevo, launched in 2003, combines levodopa, carbidopa and entacapone, ... Free with registration - Chemist & Druggist - AccessMyLibrary.com

Medical and Surgical Treatment for Parkinson Disease  -  Apr 13, 2006
Entacapone is in a group of drugs called catechol-Omethyltransferase (COMT) ... Entacapone acts in the bowels to increase the amount of levodopa absorbed. ... PsychCentral.com

A Publication of BMJ Publishing Group  -  Apr 1, 2007
One systematic review found that in persons taking levodopa, the catechol O-methyltransferase (COMT) inhibitors entacapone and tolcapone reduced "off" time, ... AAFP News Now

La rasagiline dans le traitement de la maladie de Parkinson  -  Mar 15, 2005
En plus de la dose de levodopa, les patients ont été traités par rasagiline (1 mg par voie orale une fois par jour), entacapone (200 mg chaque jour) ou ... Caducée.net

Clinical: Parkinson's disease.(Disease/Disorder overview)  -  Feb 23, 2007
Entacapone is a catechol-O-methyl transferase inhibitor (COMTI) that functions ... It is only recommended as second line to entacapone and requires careful ... Free with registration - GP - AccessMyLibrary.com

FPIN's Clinical Inquiries  -  Aug 1, 2005
The combination of levodopa and carbidopa, with entacapone ([Comtan] a selective and reversible catechol O-methyltransferase inhibitor) is suggested for ... AAFP News Now

Article: PATIO PAELLA ; SAFFRON-RICE DISH PERFECT FOR GET- …  -  Jul 2, 2008
Article: WIPO: Inventors in Spain Develop Entacapone Preparation ... US Fed News Service, Including US State News; November 29, 2008 ; 423 words . ... Pay-Per-View - The Gazette - HighBeam Research

CLINICAL REVIEW: The Treatment of Parkinson's Disease  -  Feb 15, 2005
There is a choice of two preparations, entacapone and tolcapone. Tolcapone was withdrawn from the European market because of hepatic toxicity, ... RedOrbit

Teva, Lundbeck's rasagiline shown effective in advanced Parkinson's …  -  Nov 3, 2005
An 18-week trial of 687 long-term Parkinson's patients saw rasagiline tested as an adjuvant alongside another drug in this category called entacapone, ... FinanzNachrichten.de

Adding Drug Reduces “Off Timeâ€? in Parkinson's  -  Mar 14, 2005
The authors of this study compared once-daily oral rasagiline to the drug entacapone, which must be taken with every levodopa dose, and a placebo in around ... Ivanhoe Broadcast News

Azilect can provide significant additional benefits to levodopa...  -  Sep 25, 2005
The active comparator in the study, entacapone, demonstrated comparable reductions in daily "OFF" time, but results for some of the additional measures ... Medical News Today - Medical News Today (press release)

Finnish Orion files US lawsuit to protect key drug  -  Nov 13, 2008
..."Comtan contains entacapone and is a product originated by Orion Corporation and marketed in the United States for the treatment of Parkinson's disease by ... Reuters India

Parkinson Disease: New Insights, New Treatment Options.  -  Oct 1, 2006
The COMT inhibitors entacapone and tolcapone increase the effective plasma ... Entacapone has been combined with levodopa and carbidopa in 1 tablet that is ... $4.95 - Consultant - ECNext

Federal Register 2007 - 72 FR 30386 Draft Guidances for Industry …  -  May 31, 2007
Hydrochlorothiazide Carbamazepine Carbidopa; Entacapone; Levodopa Carvedilol Cefditoren Pivoxil Celecoxib Cetirizine HCl Cevimeline HCl Cilostazol ... Pay-Per-View - Federal Register 2007 - Loislaw

•—' •— more convenient than current medicines as it combines three …  -  Apr 6, 2005
...more convenient than current medicines as it combines three drugs (levodopa, carbidopa and entacapone) in one tablet. <[etk]><[stk 3]> Nyogel an extra 12000 ... Pay-Per-View - Pharmacy News - Factiva, from Dow Jones

Agilect effective for PD symptoms; new study.(Parkinson's disease)  -  Mar 21, 2005
All patients received optimized levodopa and were randomized to receive Agilect 1mg daily, entacapone 200mg with each levodopa dose or placebo. ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones

Stalevo.(FDA actions in brief)  -  Sep 1, 2007
A new dosage strength of carbidopa, levodopa, and entacapone (Stalevo, Novartis) was approved for the treatment of Parkinson disease (PD) in patients with ... $4.95 - Formulary - ECNext

Orion Q4 profit misses consensus, shares down  -  Feb 7, 2008
The drugmaker's key patent on entacapone, on which the company's two best-selling Parkinson's disease drugs, Stalevo and Comtess/Comtan, are based, ... Reuters

A Parkinson's disease primer.(CONTINUING EDUCATION: An ongoing …  -  Oct 22, 2007
Entacapone and tolcapone are both reversible selective inhibitors of the enzyme ... While there have been no reports of hepatotoxicity with entacapone, ... $4.95 - Drug Topics - ECNext

Malattia di Parkinson: trattamento farmacologico delle complicanze …  -  Sep 4, 2007
Sebbene più potente dell'Entacapone, il Tolcapone richiede monitoraggio a causa di epatotossicità. L'Amantadina è un antagonista non competitivo del ... XagenaSalute

Rasagilina para el tratamiento de la enfermedad de Parkinson  -  Nov 8, 2006
1 mg/día de rasagilina y 200 mg de entacapone administrados junto con cada ... la administración de entacapone en este último ensayo también ocasionó el ... Intramed.net - Intramed.net (Suscripción)

FARMACI: AIFA APPROVA BANDI RICERCA E 32 PRODOTTI  -  Dec 22, 2005
Tra queste due nuovi principi attivi, l'Anagrelide monoidrato e il Levodopa carbidopa+entacapone, 18 generici-equivalenti e 6 farmaci riclassificati dalla ... Regione Basilicata

Helsinki shares end lower, led by Nokia; UPM-Kymmene gains UPDATE  -  Aug 14, 2007
...authorisation in the US to produce a generic version of entacapone, the active ingredient in Comtan, its best-selling drug for Parkinson's Disease. ... Forbes

Orion mulling lawsuit in US to protect drug patent  -  Aug 14, 2007
Orion said it is mulling options to protect its patents on entacapone, the active ingredient in Comtan, its best-selling drug for Parkinson's Disease. ... Forbes

Orion sues Wockhardt in US to block generic version of key drug  -  Sep 14, 2007
The Espoo-based firm is taking Wockhardt USA, Inc. and Wockhardt Limited to court to protect its patents on entacapone, the active ingredient in Comtan, ... Forbes

Orion Corp reiterates FY outlook after spliting into two companies  -  Jun 6, 2006
...slow down after the increase in the first months of the year, which was due to the product franchise for its Parkinson's disease treatment entacapone. ... Forbes

Orion Q4 pretax beats forecasts on strong pharma ops; sees pharma …  -  Feb 9, 2006
Looking ahead, it said it expects Orion Pharma to grow sales in 2006, boosted especially by the sales of the entacapone product franchise. ... Forbes

Orion in patent row with Sun  -  Nov 14, 2008
Comtan contains entacapone, a product developed by Orion and marketed in the US by its exclusive licensee, Novartis. Orion filed a similar suit against Sun ... Rediff

Pharmacology and pharmacokinetics of rasagiline: a selective, …  -  Aug 1, 2006
...with or without concomitant drugs (dopamine agonists, entacapone) was associated with significant improvement in PD symptoms and in motor fluctuations. ... $4.95 - Formulary - ECNext

Orion files suit against Wockhardt  -  Dec 12, 2008
The challenge is specifically for 12.5, 200, 50-mg strength of the drug, which is a combination of three drugs carbidopa, entacapone and levodopa. ... Rediff

Do brain abnormalities predate marijuana use?(Child/Adolescent …  -  Nov 1, 2007
Article: Entacapone blunts cravings in marijuana users.(ADDICITION ... Clinical Psychiatry News; March 1, 2009 ; 700+ words ... ... In an open-label pilot ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research

Takeda plummets on delays AROUND THE MARKETS BUSINESS ASIA …  -  Oct 31, 2007
One of three studies on the experimental Parkinson's disease treatment, known as entacapone, showed no advantage over a placebo, the company said. ... Pay-Per-View - International Herald Tribune - HighBeam Research

New PBS drugs to help older Australians  -  Apr 1, 2005
Stalevo is more convenient for those affected by Parkinson's disease because it is one tablet that combines three drugs - levodopa, carbidopa and entacapone ... The Age

Not about getting old ...  -  Apr 29, 2007
Dr Chew said a new three-in-one drug comprising a pharmacokinetically enhanced levodopa therapy comprising levodopa, carbidopa and entacapone was available ... Malaysia Star

Neurotoxicity of levodopa: treatment-associated homocysteine increase  -  Jan 29, 2007
...(2006) Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: a randomized controlled study. Neurology 66: 1941–1943 | Article | PubMed ... Nature.com

Weight Loss Produced by Tesofensine in Patients With Parkinson's or …  -  May 16, 2007
Concomitant treatment with levodopa, dopa decarboxylase inhibitor, dopamine agonist, entacapone, and amantadine was allowed when at a stable dose for at ... Nature.com

Nuove armi contro il Parkinson  -  May 13, 2006
Inoltre, è oggi disponibile lo stalevo, promettente preparato costituito, oltre che da levodopa, anche da entacapone e carbidopa, due inibitori degli enzimi ... Corriere della Sera

Milwaukee Journal Sentinel : DRUG CAPSULE WHAT YOU SHOULD …  -  Mar 20, 2006
Interactions: Cimetidine; ciprofloxacin; clarithromycin; diltiazem; droperidol; entacapone; erythromycin; estrogens; medicines for mental problems or ... $2.95 - Milwaukee Journal Sentinel - NewsBank

Researchers look at whether creatine slows progression of Parkinson's...  -  Mar 25, 2007
...companies and NIH in bringing five new drugs for Parkinson's disease to the market: deprenyl, lazabemide, pramipexole, clozapine, and entacapone. ... News-Medical.net

XenoPort Announces Positive Results of a Phase 1 Clinical Trial of …  -  Mar 12, 2008
It is usually administered with benzerazide or carbidopa, or a combination of carbidopa and entacapone, which delays the premature conversion of L-Dopa to ... Lifescience-online

CEO Jukka Viinanen at Orion's AGM today: Good start for the year in …  -  Mar 21, 2006
...release in February, the entacapone product purchases by the marketing partner Novartis have been relatively high during the first months of the year. ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com

New laboratory approach to treat Parkinson's  -  Mar 27, 2006
Comtan (entacapone), a so-called COMT inhibitor, has the same effect as carbidopa when taken along with levodopa. It blocks a key enzyme responsible for ... LabTechnologist.com

Study showed Agilect improved motor fluctuations and Parkinson's …  -  Feb 14, 2005
Many patients enrolled were treated, in addition to levodopa, with dopamine agonists, entacapone and/or anticholinergic medications. ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com

Valeant Pharmaceuticals Makes a Strong Showing at the Movement …  -  Mar 5, 2005
..."Entacapone to tolcapone switch study: multicenter double-blind, randomized, active-controlled trial in advanced Parkinson's disease" - Scheduled for ... RedOrbit

Four new Parkinson's disease guidelines hailed: review finds insuffici...  -  Jun 1, 2006
For motor fluctuations, the panel recommended that entacapone and rasagiline be offered, while pergolide, pramipexole, ropinirole, and tolcapone may be ... Free with registration - Clinical Psychiatry News - AccessMyLibrary.com

Schering-Plough Corporation Reports Preladenant Meets Primary …  -  Nov 24, 2008
All patients were on a stable regimen of standard treatments with L-DOPA and other adjunctive treatments, such as dopamine agonists and/or entacapone, ... Lifescience-online

Focus on the World Alzheimer's and Parkinson's Disease Market  -  Sep 15, 2008
COMT Inhibitors II-31 Tolcapone (Tasmar) II-31 Entacapone (Comtan) II-32 MAO-B Inhibitors II-32 Dopamine Amplifiers II-32 Anticholinergics II-32 7. ... marketwire.com

AAN Releases Recommendations on Treatment of Parkinson's Disease  -  Mar 15, 2007
Entacapone (Comtan) and rasagiline (Azilect) can be recommended to reduce "off" time for patients with Parkinson's disease who have motor fluctuations. ... AAFP News Now

Brand Names/Synonyms:
Entacapone is also known by the following brand names and/or synonymsComtan; ENTACAPONE; Entacapona [Inn-Spanish]; Entacapone; Entacapone [Usan:Inn]; Entacaponum [Inn-Latin]

Drug Category:
Entacapone is categorized under the following by the FDA: Antiparkinson Agents; Antidyskinetics; Central Nervous System Agents; ATC:N04BX02

Dosage Forms:
TABLET

Absorption:
Entacapone is rapidly absorbed (approximately 1 hour). The absolute bioavailability following oral administration is 35%.

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
2-cyano-3-(5-dihydroxyamino-3,4-dioxo-1-cyclohexa-1,5-dienyl)-N,N-diethyl-prop-2-enamide





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy